Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $DFTX vs $EWTX | Chartloom

Compare

$DFTX vs $EWTX

Definium Therapeutics Inc · Edgewise Therapeutics Inc

DFTX

Definium Therapeutics Inc

EWTX

Edgewise Therapeutics Inc

Compare $DFTX vs $EWTX

Comparing Definium Therapeutics Inc and Edgewise Therapeutics Inc

DFTXDefinium Therapeutics Inc

EWTXEdgewise Therapeutics Inc

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

EWTXEdgewise Therapeutics Inc

Market cap

$3.90B

P/E (TTM)

—

Forward P/E (NTM)

19.86x

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

52.8%

52W performance

140.1%

FCF yield

-4.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DFTX

EWTX

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

EWTX

Edgewise Therapeutics Inc

Market Cap

DFTX$4.28B

EWTX$3.90B

Enterprise Value

DFTX$3.67B

EWTX$3.83B

Price

DFTX$34.38

EWTX$36.28

P/E Ratio

DFTXN/A

EWTXN/A

P/S Ratio

DFTX0.00x

EWTX0.00x

EV/Sales

DFTX0.00x

EWTX0.00x

EV/EBITDA

DFTX0.00x

EWTX0.00x

P/B Ratio

DFTX5.40x

EWTX9.47x

P/FCF Ratio

DFTXN/A

EWTXN/A

EV/FCF

DFTX-21.83x

EWTX-24.12x

PEG Ratio

DFTXN/A

EWTXN/A

Forward P/E (NTM)

DFTXN/A

EWTX19.86x

Forward P/S (NTM)

DFTXN/A

EWTXN/A

Revenue (TTM)

DFTX$0

EWTX$0

Revenue Growth (YoY)

DFTXN/A

EWTXN/A

Forward Rev Growth

DFTX717.7%

EWTX0.0%

Gross Margin (TTM)

DFTX0.0%

EWTX0.0%

Operating Margin (TTM)

DFTX0.0%

EWTX0.0%

EBITDA Margin (TTM)

DFTX0.0%

EWTX0.0%

Net Margin (TTM)

DFTX0.0%

EWTX0.0%

FCF Margin (TTM)

DFTXN/A

EWTXN/A

Net Income (TTM)

DFTX$-354M

EWTX$-197M

FCF (TTM)

DFTX$-168M

EWTX$-159M

EPS (TTM)

DFTX-$3.20

EWTX-$1.83

ROE (TTM)

DFTX-8523.0%

EWTX-3901.0%

ROA (TTM)

DFTX-6458.0%

EWTX-3696.0%

ROIC (TTM)

DFTX-7781.0%

EWTX-3901.0%

Cash

DFTX$655M

EWTX$72M

Debt

DFTX$36M

EWTX$0

Net Cash/Debt

DFTX$619M

EWTX$72M

Current Ratio (TTM)

DFTX6.95x

EWTX16.24x

Quick Ratio (TTM)

DFTX6.89x

EWTX16.01x

Debt/Equity (TTM)

DFTX0.04x

EWTX0.00x

Debt/Assets (TTM)

DFTX0.0%

EWTX0.0%

Interest Coverage (TTM)

DFTXN/A

EWTXN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

EWTX0.00x

Beta

DFTX2.23

EWTX0.37

52W Performance

DFTX191.1%

EWTX140.1%

YTD Performance

DFTX152.1%

EWTX52.8%

% from 52W High

DFTX-30.8%

EWTX-25.2%

% from 52W Low

DFTX228.5%

EWTX154.6%

Asset Turnover (TTM)

DFTX0.00x

EWTX0.00x

FCF Yield (TTM)

DFTX-3.9%

EWTX-4.1%

Earnings Yield (TTM)

DFTX-8.3%

EWTX-5.1%

Dividend Yield (TTM)

DFTXN/A

EWTXN/A

Rule of 40

DFTX0.0

EWTX0.0

EV/GP/RG

DFTXN/A

EWTXN/A

Ticker research

View DFTX research View EWTX research

Metric	DFTX Definium Therapeutics Inc	EWTX Edgewise Therapeutics Inc
Market & Valuation
Market Cap	$4.28B	$3.90B
Enterprise Value	$3.67B	$3.83B
Price	$34.38	$36.28
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.40x	9.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-24.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	19.86x
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	717.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-354M	$-197M
FCF (TTM)	$-168M	$-159M
EPS (TTM)	-$3.20	-$1.83
ROE (TTM)	-8523.0%	-3901.0%
ROA (TTM)	-6458.0%	-3696.0%
ROIC (TTM)	-7781.0%	-3901.0%
Financial Health
Cash	$655M	$72M
Debt	$36M	$0
Net Cash/Debt	$619M	$72M
Current Ratio (TTM)	6.95x	16.24x
Quick Ratio (TTM)	6.89x	16.01x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	0.37
52W Performance	191.1%	140.1%
YTD Performance	152.1%	52.8%
% from 52W High	-30.8%	-25.2%
% from 52W Low	228.5%	154.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.9%	-4.1%
Earnings Yield (TTM)	-8.3%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DFTX research	View EWTX research

Valuation

P/S Ratio

DFTX

0.00x

EWTX

0.00x

EV/FCF

EWTX

-24.12x

DFTX

-21.83x

Growth & revenue

Forward Revenue Growth

DFTX

717.7%

EWTX

0.0%

Profitability & performance

Gross Margin

DFTX

0.0%

EWTX

0.0%

ROE

EWTX

-3901.0%

DFTX

-8523.0%

FCF Yield %

DFTX

-3.9%

EWTX

-4.1%

52-Week Performance

DFTX

191.1%

EWTX

140.1%

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

EWTX

Edgewise Therapeutics Inc

Market Cap

DFTX$4.28B

EWTX$3.90B

Enterprise Value

DFTX$3.67B

EWTX$3.83B

Price

DFTX$34.38

EWTX$36.28

P/E Ratio

DFTXN/A

EWTXN/A

P/S Ratio

DFTX0.00x

EWTX0.00x

EV/Sales

DFTX0.00x

EWTX0.00x

EV/EBITDA

DFTX0.00x

EWTX0.00x

P/B Ratio

DFTX5.40x

EWTX9.47x

P/FCF Ratio

DFTXN/A

EWTXN/A

EV/FCF

DFTX-21.83x

EWTX-24.12x

PEG Ratio

DFTXN/A

EWTXN/A

Forward P/E (NTM)

DFTXN/A

EWTX19.86x

Forward P/S (NTM)

DFTXN/A

EWTXN/A

Revenue (TTM)

DFTX$0

EWTX$0

Revenue Growth (YoY)

DFTXN/A

EWTXN/A

Forward Rev Growth

DFTX717.7%

EWTX0.0%

Gross Margin (TTM)

DFTX0.0%

EWTX0.0%

Operating Margin (TTM)

DFTX0.0%

EWTX0.0%

EBITDA Margin (TTM)

DFTX0.0%

EWTX0.0%

Net Margin (TTM)

DFTX0.0%

EWTX0.0%

FCF Margin (TTM)

DFTXN/A

EWTXN/A

Net Income (TTM)

DFTX$-354M

EWTX$-197M

FCF (TTM)

DFTX$-168M

EWTX$-159M

EPS (TTM)

DFTX-$3.20

EWTX-$1.83

ROE (TTM)

DFTX-8523.0%

EWTX-3901.0%

ROA (TTM)

DFTX-6458.0%

EWTX-3696.0%

ROIC (TTM)

DFTX-7781.0%

EWTX-3901.0%

Cash

DFTX$655M

EWTX$72M

Debt

DFTX$36M

EWTX$0

Net Cash/Debt

DFTX$619M

EWTX$72M

Current Ratio (TTM)

DFTX6.95x

EWTX16.24x

Quick Ratio (TTM)

DFTX6.89x

EWTX16.01x

Debt/Equity (TTM)

DFTX0.04x

EWTX0.00x

Debt/Assets (TTM)

DFTX0.0%

EWTX0.0%

Interest Coverage (TTM)

DFTXN/A

EWTXN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

EWTX0.00x

Beta

DFTX2.23

EWTX0.37

52W Performance

DFTX191.1%

EWTX140.1%

YTD Performance

DFTX152.1%

EWTX52.8%

% from 52W High

DFTX-30.8%

EWTX-25.2%

% from 52W Low

DFTX228.5%

EWTX154.6%

Asset Turnover (TTM)

DFTX0.00x

EWTX0.00x

FCF Yield (TTM)

DFTX-3.9%

EWTX-4.1%

Earnings Yield (TTM)

DFTX-8.3%

EWTX-5.1%

Dividend Yield (TTM)

DFTXN/A

EWTXN/A

Rule of 40

DFTX0.0

EWTX0.0

EV/GP/RG

DFTXN/A

EWTXN/A

Ticker research

View DFTX research View EWTX research

Metric	DFTX Definium Therapeutics Inc	EWTX Edgewise Therapeutics Inc
Market & Valuation
Market Cap	$4.28B	$3.90B
Enterprise Value	$3.67B	$3.83B
Price	$34.38	$36.28
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.40x	9.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-24.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	19.86x
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	717.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-354M	$-197M
FCF (TTM)	$-168M	$-159M
EPS (TTM)	-$3.20	-$1.83
ROE (TTM)	-8523.0%	-3901.0%
ROA (TTM)	-6458.0%	-3696.0%
ROIC (TTM)	-7781.0%	-3901.0%
Financial Health
Cash	$655M	$72M
Debt	$36M	$0
Net Cash/Debt	$619M	$72M
Current Ratio (TTM)	6.95x	16.24x
Quick Ratio (TTM)	6.89x	16.01x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	0.37
52W Performance	191.1%	140.1%
YTD Performance	152.1%	52.8%
% from 52W High	-30.8%	-25.2%
% from 52W Low	228.5%	154.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.9%	-4.1%
Earnings Yield (TTM)	-8.3%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DFTX research	View EWTX research